Vimarsana
Biggest News Aggregation in the World

Adolescent Immunization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adolescent Immunization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adolescent Immunization Today - Breaking & Trending Today

CDC Recommends Routine Use of Beyfortus for RSV Disease Prevention in Infants - Vimarsana News

CDC Recommends Routine Use of Beyfortus for RSV Disease Prevention in Infants

The CDC has unanimously voted to recommend routine use of the anti-RSV monoclonal antibody Beyfortus to prevent RSV disease in infants.

Source: empr.com
Solutions to Vaccine Troubles in Ten Sentences - Vimarsana News

Solutions to Vaccine Troubles in Ten Sentences

Religious faith has tremendous potential for good in society, but when it is misrepresented as science, its track record is miserable and deadly.

Prominent Doctor: Let's Face It, the CDC Is the Anti-Vax Movement's Top Recruiter Right Now - Vimarsana News

Prominent Doctor: Let's Face It, the CDC Is the Anti-Vax Movement's Top Recruiter Right Now

 

The Defender - 'Tragic': CDC Adds Original COVID mRNA Vaccine to Childhood Schedule Despite Known Harms - Vimarsana News

The Defender - 'Tragic': CDC Adds Original COVID mRNA Vaccine to Childhood Schedule Despite Known Harms

Children's Health Defense explains impact of the CDC Decision to add the Covid vaccine series to the pediatric schedule. Mandates mean that parents will be faced with decisions so many in the autism vaccine injury community have faced for decades....

'Tragic': CDC adds original COVID mRNA vaccine to childhood schedule despite known harms - Vimarsana News

'Tragic': CDC adds original COVID mRNA vaccine to childhood schedule despite known harms

The Centers for Disease Control and Prevention (CDC) on Thursday added COVID-19 vaccination to its routine immunization schedule for children and adults. (Article by Brenda Baletti, Ph.D. [...]